Vitamin D in Midlife Linked to Lower Tau Protein Levels, Study Finds
An international study led by the University of Galway has found that higher levels of vitamin D in middle age are associated with lower levels of tau protein in the brain years later—a key biomarker linked to Alzheimer’s disease. The research, published in Neurology Open Access, analyzed blood samples and brain scans from nearly 800 adults who did not have dementia at the start of the study. Participants had their vitamin D levels measured at an average age of 39, and brain imaging conducted approximately 16 years later was used to assess tau and amyloid-beta accumulation.
Whereas the study does not prove causation, it identifies a significant statistical association: individuals with higher vitamin D levels in midlife tended to have fewer tau tangles in later brain scans. Tau protein tangles, when abnormal, are strongly implicated in the neurodegenerative processes seen in Alzheimer’s disease. Researchers emphasized that the findings suggest vitamin D may be a modifiable factor that could contribute to long-term brain health, though further studies are needed to confirm whether increasing vitamin D intake directly reduces dementia risk.
The study was conducted in collaboration with Boston University, the Framingham Heart Study, and the University of Texas San Antonio. Senior author Professor Emer McGrath, Associate Professor in Medicine at the University of Galway and Consultant Neurologist at Galway University Hospital, stated that the results support the idea that maintaining adequate vitamin D levels during midlife could be a meaningful step toward protecting future brain health. She noted that while vitamin D is available through sunlight, diet, and supplements, individuals should consult healthcare providers before making significant changes to their supplementation routines.
Experts caution that although the link between vitamin D and reduced tau burden is promising, it remains an observational finding. No participants in the study had been diagnosed with Alzheimer’s at the time of brain imaging; instead, tau and amyloid-beta levels were used as biomarkers for early Alzheimer’s-related changes. The research team called for additional longitudinal and interventional studies to determine whether vitamin D supplementation can actively prevent or delay cognitive decline.
As interest grows in nutritional approaches to brain aging, this study adds to a growing body of evidence suggesting that lifestyle factors in midlife may influence neurological outcomes decades later. For now, maintaining balanced nutrition—including sufficient vitamin D—remains a reasonable component of a broader strategy for long-term cognitive wellness.